Because GLP-1R and GIPR are central components of incretin physiology, GLP-RTallows researchers to explore how simultaneous receptor activation influences cyclic AMP signaling, hormone secretion pathways, and metabolic regulatory networks
Currently, there are 9 GLP-1RAs approved by the FDA, widely used for the treatment of type 2 diabetes
But do these products live up to the hype and more importantly, are they safe
Incretin Pathway Dynamics: Studying receptor-binding behavior, signaling duration, and feedback mechanisms within incretin-associated signaling systems
doi: 10.3390/ijms26041651
This will determine if youre able to take part in the program